NCT03660293View on ClinicalTrials.gov

Prediction and Prevention of Asymptomatic Cardiovascular Insult in Type 1 Diabetic Children: Comparative Effectiveness of Cardioprotective Drugs

NACompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

June 1, 2019

Study Completion Date

June 1, 2019

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG

Atorvastatin

cardio-protective agents

DRUG

Captopril

cardio-protective agents

DRUG

L-carnitine

cardio-protective agents

Trial Locations (1)

0000

Faculty of Medicine- Tanta University, Tanta

All Listed Sponsors

lead

Tanta University

OTHER

NCT03660293 - Prediction and Prevention of Asymptomatic Cardiovascular Insult in Type 1 Diabetic Children: Comparative Effectiveness of Cardioprotective Drugs | Biotech Hunter | Biotech Hunter